Blood test may predict success of liver surgery for rare eye cancer
NCT ID NCT02849145
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 35 times
Summary
This study looked at whether measuring tumor DNA in the blood can help track uveal melanoma that has spread to the liver. Researchers took blood samples from 60 patients before and after surgery to remove liver tumors. The goal was to see if changes in tumor DNA levels could show whether the surgery was successful and help predict when the cancer might come back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.